| 2061 |
FEROCIT TR |
DRIED FERROUS SULPHATE BP 150 MG ,
FOLIC ACID BP 0.5 MG |
CAPSULE |
ALU-PVC BLISTER |
FEROCIT TR IS INDICATED FOR THE PREVENTION AND TREATMENT OF IRON AND FOLIC ACID DEFICIENCIES SPECIALLY DURING PREGNANCY AND LACTATION. |
NULL |
PALAMY PHARMA CO., LTD |
THE ACME LABORATORIES LTD. |
BANGLADESH |
CERTIFICATE RELEASED |
03 I 3736/12 |
31-Mar-2023 |
30-Mar-2026 |
View |
| 2062 |
FERROGLOBIN |
EACH 5 ML CONTAINS: FERROUS SULPHATE BP 200 MG EQ.TO IRON 40 MG |
SYRUP |
BOTTLE |
FERROGLOBIN IS INDICATED IN IRON DEFICIENCY ANAEMIA, OVER WORK, HAEMORRHAGE, PREGNANCY, GLOSSITIS AND HELMINTHIASIS |
NULL |
PALAMY PHARMA CO., LTD |
THE ACME LABORATORIES LTD. |
BANGLADESH |
CERTIFICATE RELEASED |
03 I 3749/12 |
31-Mar-2023 |
30-Mar-2026 |
View |
| 2063 |
FLAMYD 500 |
METRONIDAZOLE BP 500MG |
TABLET |
ALU-PVC BLISTER |
THE PREVENTION OF POST-OPERATIVE INFECTIONS DUE TO ANAEROBIC BACTERIA, UROGENITAL TRICHOMONIASIS, ALL FORMS OF AMOEBIASIS, BACTERIAL VAGINOSIS, GIARDIASIS, ACUTE ULCERATIVE GINGIVITIS, ANAEROBICALLY-INFECTED LEG ULCERS AND PRESSURE SORES, H. PYLORI INFECTION, ACUTE DENTAL INFECTIONS DUE TO ANAEROBIC ORGANISMS. |
NULL |
PALAMY PHARMA CO., LTD |
INCEPTA PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
05 I 3320/09 |
23-NOV-2023 |
22-Nov-2026 |
View |
| 2064 |
GLICLID |
GLICLAZIDE BP 80 MG |
TABLET |
ALU-PVC BLISTER |
INDICATED IN NON-INSULIN DEPENDENT DIABETES (TYPE II) WHEN DIETARY MODIFICATION HAS FAILED |
NULL |
PALAMY PHARMA CO., LTD |
THE ACME LABORATORIES LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
12 I 5828/24 |
16-DEC-2024 |
15-DEC-2029 |
View |
| 2065 |
GLITO-30 |
PIOGLITAZONE HYDROCHLORIDE EQ.TO PIOGLITAZONE 30 MG |
TABLET |
ALU-PVC BLISTER |
IS INDICATED AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES (NON-INSULIN DEPENDENT DIABETES MELLITUS, NIDDM)… |
NULL |
PALAMY PHARMA CO., LTD |
MEDLEY PHARMACEUTICALS LTD |
INDIA |
CERTIFICATE RELEASED |
07 I 3387/09 |
23-NOV-2023 |
22-Nov-2026 |
View |
| 2066 |
GYNAEMINE |
ERGOTAMINE TARTRATE 0.25 MG, ERGOMETRINE MALEATE 0.125 MG |
SUGAR COATED TABLET |
BOTTLE |
ANALGESIC |
NULL |
PALAMY PHARMA CO., LTD |
SRIPRASIT PHARMA CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
04 I 1215/97 |
31-Mar-2023 |
30-Mar-2026 |
View |
| 2067 |
HERPENON CREAM |
EACH 100 G CONTAINS: ACYCLOVIR 5G |
CREAM |
Tube |
FOR TREATMENT OF TOPICAL VIRUS INFECTION SUCH AS: HERPES SIMPLEX VIRUS, INCLUDING INITIAL AND RECURRENT GENITAL HERPES AND HERPES LABIALIS. |
NULL |
PALAMY PHARMA CO., LTD |
POLIPHARM CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
12 I 4119/15 |
2-Feb-2023 |
01-Feb-2026 |
View |
| 2068 |
HERPENON TAB |
ACYCLOVIR 200 MG |
TABLET |
PVC-ALU BLISTER |
FOR THE TREATMENT OF HERPES SIMPLEX INFECTIONS OF SKIN AND MUCOUS MEMBRANES, INCLUDING INITIAL AND RECURRENT GENITAL HERPES, FOR THE SUPPRESSION OF RECURRENT AND PROPHYLAXIS OF HERPES SIMPLEX INFECTIONS IN IMMUNE-COMPROMISED PATIENTS, TREATMENT OF VARICELLA AND HERPES ZOSTER INFECTIONS, |
NULL |
PALAMY PHARMA CO., LTD |
POLIPHARM CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
03 I 3727/12 |
2-Feb-2023 |
01-Feb-2026 |
View |
| 2069 |
KEFODIME DRY SYRUP |
CEFPODOXIME PROXETIL USP EQUIVALENT TO CEFPODOXIME 50 MG/ 5 ML |
ORAL SUSPENSION |
BOTTLE |
TREATMENT OF PATIENTS WITH MILD TO MODERATED INFECTIONS CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICROORGANISMS, UPPER AND LOWER RESPIRATORY TRACT INFECTION, SKIN AND SOFT TISSUE INFECTION,UNCOMPLICATED URINARY TRACT INFECTION |
NULL |
PALAMY PHARMA CO., LTD |
MEDLEY PHARMACEUTICALS LTD |
INDIA |
CERTIFICATE RELEASED |
11 I 3982/13 |
16-JAN-2025 |
15-JAN-2030 |
View |
| 2070 |
KETONAZOLE CREAM |
KETOCONAZOLE 2G/100 G |
CREAM |
TUBE |
FOR THE TREATMENT OF THE SKIN NAIL INFECTIONS DUE TO DERMATOPHYTE AND YEASTS. |
NULL |
PALAMY PHARMA CO., LTD |
POLIPHARM CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
11 I 3931/13 |
19-MAY-2023 |
18-MAY-2026 |
View |
